{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-10660", "FDA", "Requests that the FDA take administrative actions regarding drug products containing ethinylestradiol (also known as 17\u03b1-ethinylestradiol or EE2) and combined oral contraceptives that contain ethinylestradiol.", "Nonrulemaking", "2026-09-11T15:33:55Z", "0b000064b951d315", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-10660"], "units": {}, "query_ms": 0.3329371102154255, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}